Orbimed Advisors LLC Kezar Life Sciences, Inc. Call Options Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
Call Options
2 transactions
Others Institutions Holding KZR
# of Institutions
86Shares Held
45MCall Options Held
2.6KPut Options Held
600-
Suvretta Capital Management, LLC New York, NY7.17MShares$4.16 Million0.28% of portfolio
-
Avidity Partners Management LP Dallas, TX5.03MShares$2.92 Million0.17% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$2.68 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$1.79 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.05MShares$1.19 Million0.29% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $39.7M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...